Antiarrhythmic therapy: new additions and future expectations.
D000120:Acecainide / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000813:Anilides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001073:Aprindine / Q000627:therapeutic use; D001950:Bretylium Tosylate / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D016700:Encainide; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D016677:Tocainide; D014700:Verapamil / Q000627:therapeutic use
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D016677:Tocainide; D001073:Aprindine; D001950:Bretylium Tosylate; D000120:Acecainide; D008012:Lidocaine; D014700:Verapamil; D004206:Disopyramide; D000638:Amiodarone; D016700:Encainide